AstraZeneca R&D: Turning science into medicine
Introducing AstraZeneca R&D
We are driven by science, united by science, and every day, we push the boundaries of science to deliver life-changing medicines.
What science can do
We are never complacent about scientific discovery and development, always pushing our R&D productivity, searching for new knowledge and the next breakthrough.
Transforming our science
Guided by our ‘Growth Through Innovation’ strategy, we are committed to investing in four areas, which will help us in our aspiration to create the greatest and swiftest impact on disease.
Our people are our power
Our business and scientific culture is diverse, inclusive and collaborative, and we do everything in our power to enable all our people to be the best they can be.
Senior Director and Head of Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D
R&D focus areas
Our unique scientific capabilities enable us to deliver what we believe to be one of the most productive pipelines in the industry.
Strategic science centres
We have three strategic R&D centres in the UK, US and Sweden, as well as an active R&D presence in 40 other countries spanning the globe.
To achieve all we want to achieve, we cannot do it alone.